0,919  0,005  Antiinflammatory
0,896  0,006  Transcription factor NF kappa B inhibitor
0,872  0,009  Apoptosis agonist
0,826  0,007  TNF expression inhibitor
0,798  0,005  Chemopreventive
0,782  0,004  Nitric oxide antagonist
0,786  0,009  Antineoplastic (lung cancer)
0,781  0,014  Caspase 9 stimulant
0,751  0,014  Antineoplastic (breast cancer)
0,714  0,004  Antineoplastic (lymphoma)
0,715  0,012  Antileukemic
0,700  0,005  Antipsoriatic
0,694  0,008  Bone diseases treatment
0,668  0,004  Hair growth stimulant
0,650  0,001  Abortion inducer
0,641  0,005  Antineoplastic (multiple myeloma)
0,639  0,008  Hepatic disorders treatment
0,622  0,005  Renal disease treatment
0,625  0,013  Sensitization
0,612  0,010  Antiosteoporotic
0,611  0,015  Chemoprotective
0,594  0,006  Antineoplastic enhancer
0,583  0,012  Cardioprotectant
0,592  0,024  Antineoplastic (colorectal cancer)
0,590  0,023  Antineoplastic (colon cancer)
0,583  0,020  Prostate cancer treatment
0,569  0,011  Antifungal
0,565  0,016  Antineoplastic (melanoma)
0,568  0,025  Antibacterial
0,560  0,019  Antineoplastic (ovarian cancer)
0,543  0,014  Antiparasitic
0,536  0,009  Antihelmintic
0,535  0,013  Antiprotozoal (Leishmania)
0,540  0,022  Antipruritic, allergic
0,523  0,007  Antiulcerative
0,524  0,013  Antipyretic
0,530  0,021  Carcinogenic
0,510  0,005  Interferon gamma antagonist
0,507  0,005  Antiacne
0,524  0,027  Atherosclerosis treatment
0,517  0,020  Antineoplastic (pancreatic cancer)
0,526  0,030  Teratogen
0,500  0,005  Contraceptive
0,500  0,019  Antineoplastic (glioma)
0,499  0,020  Lipoprotein disorders treatment
0,510  0,039  CYP3A4 substrate
0,501  0,031  Embryotoxic
0,482  0,023  AR expression inhibitor
0,493  0,035  Immunosuppressant
0,460  0,009  Hepatoprotectant
0,477  0,028  Cytotoxic
0,456  0,014  Skin irritative effect
0,467  0,026  Antineoplastic (cervical cancer)
0,469  0,030  Antihypercholesterolemic
0,470  0,033  Respiratory analeptic
0,450  0,015  UDP-glucuronosyltransferase substrate
0,443  0,008  Prostate disorders treatment
0,449  0,016  Antineoplastic (liver cancer)
0,437  0,004  Androgen antagonist
0,486  0,055  Cyclophilin D inhibitor
0,486  0,055  Antidiabetic
0,437  0,010  Prostatic (benign) hyperplasia treatment
0,457  0,030  Immunomodulator
0,430  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,425  0,009  UGT2B7 substrate
0,437  0,023  CYP3A4 inhibitor
0,437  0,030  NOS3 expression inhibitor
0,424  0,018  Antineoplastic (endocrine cancer)
0,434  0,031  Analeptic
0,426  0,023  Antineoplastic (glioblastoma multiforme)
0,430  0,035  Caspase 3 stimulant
0,392  0,004  Contraceptive female
0,417  0,029  NOS2 expression inhibitor
0,395  0,011  Antipruritic, non-allergic
0,409  0,028  Proliferative diseases treatment
0,400  0,018  Transcription factor STAT3 inhibitor
0,386  0,020  Sedative
0,416  0,055  CYP2C19 inhibitor
0,379  0,028  Antineoplastic (renal cancer)
0,376  0,026  Sodium/bile acid cotransporter inhibitor
0,376  0,026  Angiogenesis stimulant
0,379  0,033  Calcium channel activator
0,388  0,043  Antineoplastic (brain cancer)
0,383  0,038  Antioxidant
0,341  0,004  TRPA1 agonist
0,368  0,034  Mutagenic
0,372  0,038  UGT2B4 substrate
0,328  0,005  Choleretic
0,320  0,009  Cholesterol synthesis inhibitor
0,343  0,037  Transcription factor STAT inhibitor
0,319  0,016  Protein-tyrosine phosphatase inhibitor
0,366  0,065  Inflammatory Bowel disease treatment
0,325  0,026  Platelet adhesion inhibitor
0,308  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,341  0,043  Antineoplastic (osteosarcoma)
0,327  0,035  Antineoplastic (lymphocytic leukemia)
0,333  0,043  Platelet antagonist
0,292  0,007  Antieczematic
0,326  0,045  Tumour necrosis factor alpha release inhibitor
0,346  0,065  Immunostimulant
0,285  0,004  Transcription factor NF kappa B stimulant
0,341  0,060  Apoptosis antagonist
0,286  0,007  Contraceptive male
0,303  0,032  Growth hormone agonist
0,336  0,068  ICAM1 expression inhibitor
0,267  0,004  Hypercalcemia treatment
0,370  0,108  Antiarthritic
0,258  0,002  ATP citrate lysase inhibitor
0,340  0,085  CYP2C9 substrate
0,264  0,015  Antifungal enhancer
0,264  0,015  Pulmonary hypertension treatment
0,296  0,050  Hypolipemic
0,262  0,022  Antiviral (Influenza A)
0,250  0,011  Farnesoid X receptor antagonist
0,316  0,081  Cholesterol antagonist
0,243  0,010  Microtubule formation inhibitor
0,270  0,039  Antiviral (Influenza)
0,298  0,067  CYP2C19 substrate
0,262  0,032  Neurotrophic factor enhancer
0,232  0,005  CDC25A inhibitor
0,263  0,038  Non-steroidal antiinflammatory agent
0,224  0,004  5-Alpha-reductase inhibitor
0,263  0,043  UGT1A1 substrate
0,287  0,069  Antidiabetic (type 2)
0,217  0,008  Adenylate cyclase stimulant
0,208  0,005  Lipase inhibitor
0,238  0,038  Lipocortins synthesis antagonist
0,247  0,047  Antialcoholic
0,203  0,005  Progesterone antagonist
0,195  0,005  Anabolic
0,201  0,012  Vanilloid 1 agonist
0,192  0,005  Androgen agonist
0,186  0,005  Bile acid receptor antagonist
0,214  0,033  UGT2B9 substrate
0,183  0,004  Hyperparathyroidism treatment
0,253  0,076  Antineoplastic (non-small cell lung cancer)
0,264  0,086  Antihypoxic
0,248  0,074  Cardiovascular analeptic
0,181  0,007  Antiviral (SARS coronavirus)
0,181  0,007  Antiviral (Coronavirus)
0,203  0,030  Arachidonic acid antagonist
0,203  0,035  Uterine stimulant
0,169  0,004  Na+ K+ transporting ATPase inhibitor
0,201  0,036  UGT2B10 substrate
0,172  0,015  Actinic keratosis treatment
0,170  0,013  ABCA1 expression enhancer
0,198  0,042  Lipid peroxidase inhibitor
0,212  0,058  Sigma receptor agonist
0,175  0,023  Alcohol dehydrogenase substrate
0,206  0,055  UGT1A4 substrate
0,275  0,124  Stroke treatment
0,239  0,093  Gastrin inhibitor
0,146  0,003  Vitamin D receptor antagonist
0,270  0,128  GST A substrate
0,215  0,075  Antiparkinsonian, rigidity relieving
0,185  0,047  Protein kinase stimulant
0,165  0,028  Antineoplastic antibiotic
0,191  0,056  UGT1A3 substrate
0,184  0,050  Antineoplastic (carcinoma)
0,147  0,016  UGT2B11 substrate
0,134  0,003  Postcoital contraceptive
0,181  0,051  Melanin inhibitor
0,155  0,026  Antineoplastic alkaloid
0,229  0,101  Spasmolytic
0,201  0,074  Anesthetic general
0,189  0,064  LDLR expression enhancer
0,175  0,051  Antineoplastic (squamous cell carcinoma)
0,141  0,018  Inducible nitric-oxide synthase inhibitor
0,160  0,038  Pregnane X receptor agonist
0,125  0,011  Narcotic antagonist
0,177  0,066  Antineoplastic (bone cancer)
0,183  0,074  Antiviral (Hepatitis)
0,111  0,005  Heme oxygenase stimulant
0,156  0,051  Psychosexual dysfunction treatment
0,108  0,003  Parathyroid hormone antagonist
0,135  0,035  Antiinfertility, female
0,125  0,027  Paget's disease treatment
0,191  0,095  Cardiodepressant
0,100  0,008  Potassium channel Kv1.3 blocker
0,135  0,044  Endometrios treatment
0,141  0,051  Antiviral (Hepatitis B)
0,112  0,024  Keratolytic
0,153  0,065  Antidiabetic (type 1)
0,148  0,061  Bone formation stimulant
0,158  0,072  Antiviral (Herpes)
0,198  0,114  Hypoglycemic
0,157  0,074  Eye irritation, high
0,191  0,109  Cytostatic
0,107  0,026  Vanilloid agonist
0,225  0,149  Vasodilator, peripheral
0,244  0,169  Antiprotozoal
0,103  0,030  Glycine receptor antagonist
0,117  0,047  Sulfotransferase substrate
0,126  0,056  Menstruation disorders treatment
0,137  0,069  Anesthetic
0,069  0,002  Vitamin D receptor agonist
0,115  0,053  UGT2B1 substrate
0,063  0,003  Progesterone receptor B antagonist
0,088  0,030  Glycine receptor agonist
0,176  0,118  Antiviral (HIV)
0,155  0,097  Antineoplastic (gastric cancer)
0,083  0,026  Aromatase inhibitor
0,066  0,009  Glucocorticoid antagonist
0,099  0,043  Antispirochetal
0,067  0,011  Retinoid X receptor agonist
0,212  0,158  Antihypertensive
0,194  0,144  Antiepileptic
0,133  0,083  UGT2B15 substrate
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,070  0,022  Lipocortins synthesis agonist
0,065  0,017  Mineralocorticoid receptor antagonist
0,071  0,026  Postmenopausal disorders treatment
0,142  0,097  Muscle relaxant
0,049  0,005  Retinoid X gamma receptor agonist
0,058  0,014  Liver X receptor alpha agonist
0,180  0,138  Antiprotozoal (Trypanosoma)
0,180  0,139  Interleukin agonist
0,113  0,072  Proteasome inhibitor
0,153  0,113  Antieczematic atopic
0,048  0,009  Prostaglandin D2 agonist
0,051  0,013  RNA-directed RNA polymerase stimulant
0,047  0,013  Cholesterol absorption inhibitor
0,055  0,022  Microtubule stabilization
0,089  0,057  Ornithine decarboxylase inhibitor
0,119  0,087  Skin whitener
0,037  0,006  Retinoid X gamma receptor antagonist
0,054  0,023  Adenylate cyclase 1 inhibitor
0,158  0,128  Pneumotoxic
0,182  0,151  DNA synthesis inhibitor
0,037  0,006  Retinoid X beta receptor agonist
0,037  0,008  CYP24 inhibitor
0,054  0,025  Aldosterone antagonist
0,051  0,022  Liver X receptor agonist
0,084  0,055  Antiprotozoal activity enhancer
0,040  0,011  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,043  0,017  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,144  0,119  Phospholipase C inhibitor
0,042  0,018  Retinoid X alpha receptor agonist
0,029  0,005  Retinoid X beta receptor antagonist
0,038  0,015  Prostaglandin agonist
0,205  0,184  GST M1-1 substrate
0,162  0,141  Vasodilator
0,027  0,008  Retinoic acid gamma receptor agonist
0,144  0,126  P-glycoprotein inhibitor
0,049  0,031  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,052  0,034  Anesthetic inhalation
0,067  0,050  Andropause treatment
0,072  0,054  Antibiotic
0,028  0,010  Prostaglandin F2 alpha agonist
0,126  0,109  Antifungal (Cryptococcus)
0,068  0,051  Anticholelithogenic
0,065  0,049  Leukotriene synthesis inhibitor
0,151  0,135  CYP2B6 inhibitor
0,169  0,154  5 Hydroxytryptamine release stimulant
0,040  0,025  Retinoic acid alpha receptor agonist
0,100  0,086  DNA polymerase I inhibitor
0,026  0,013  Retinoic acid receptor agonist
0,108  0,096  Antihyperlipoproteinemic
0,080  0,068  3C-Like protease (SARS coronavirus) inhibitor
0,030  0,019  Liver X receptor alpha antagonist
0,039  0,028  GABA uptake inhibitor
0,034  0,024  Retinoid X alpha receptor antagonist
0,037  0,028  Glucose-6-phosphate dehydrogenase inhibitor
0,194  0,185  Antithrombotic
0,021  0,012  Retinoic acid beta receptor agonist
0,037  0,028  Retinoid X receptor antagonist
0,129  0,121  Dual specificity phosphatase inhibitor
0,038  0,030  Membrane dipeptidase inhibitor
0,214  0,206  Rheumatoid arthritis treatment
0,127  0,119  Dual specificity phosphatase 3 inhibitor
0,033  0,026  HMG CoA reductase inhibitor
0,018  0,012  Progesterone agonist
0,026  0,019  Nicotinic acid receptor 2 antagonist
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,021  0,015  Corticosteroid-like
0,007  0,002  Vitamin D-like
0,048  0,043  Protein 50S ribosomal subunit inhibitor
0,168  0,165  Huntington's disease treatment
0,028  0,026  Liver X receptor antagonist
0,204  0,203  Antiobesity
0,031  0,031  Tubulin agonist

